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Two articles in this month’s issue of Anesthesia & Analgesia present novel
analgesic concepts. The paper by Aasvang et al.1 explores the effect of
instilling capsaicin into the wound during surgery. In the absence of some
form of anesthesia, the capsaicin would be intensely painful. However,
since the wound is also anesthetized using local, regional, or general
anesthesia, the patient does not experience the immediate pain from
C-fiber activation. Instead, C fibers innervating the wound are rendered
inactive from the calcium influx, providing long lasting postoperative
analgesia. Also in this issue, the paper by Zeidan et al.2 demonstrates the
analgesic utility of instilling a combination of tramadol and bupivacaine
into the knee following arthroscopic knee surgery. The combination
provides superior analgesia to either drug given alone.
What is unique about these papers is that the analgesic response was
analyzed using a program unfamiliar to most analgesic investigators:
NONMEM.3 NONMEM is a software program for nonlinear mixed effects
modeling developed by Lewis Sheiner and Stuart Beal at the University of
California. NONMEM was primarily developed to analyze pharmacoki-
netic data, and grew out of the recognition that pharmacokinetic data
typically have two sources of variability: interpatient variability (how each
patient’s volumes and clearances were different from a “typical” patient)
and residual intrasubject variability (assay noise, model misspecification,
and other sources of noise). The bifurcation of variability into true
biological variability, how we all differ from each other, and residual noise
ushered in an era of individualized pharmacokinetics and therapeutic drug
monitoring.
The authors of these two papers did not independently decide to
analyze their data using NONMEM. Instead, their initial submissions
reflected more traditional analyses that did not take full advantage of the
repeated measures in their study design. For example, in the original
submission on the effect of capsaicin, the analgesic effect was reported as
a trend that did not reach statistical significance. Visual examination of the
data during peer review clearly demonstrated that the groups were
different at every point in time. The inability to distinguish this in the
analysis was an artifact of the statistical approach.
Mixed effects analysis with NONMEM brought two unique aspects to
the data analysis of these trials. Since pain is highly subjective, subjects
differ enormously in their sensitivity to pain and their response to
analgesics. A statistical approach must be able to isolate and characterize
intersubject variability. Second, the analgesic response is not constant, but
follows its own unique time course. Does the analgesia last for one day?
Two days? Three days? Four days? Is the effect the same each day, or does
it change over time?
These characteristics play to NONMEM’s strengths. NONMEM can
analyze intersubject variability (i.e., the unique sensitivity of subjects to
pain and pain relief), and permits the analyst to precisely characterize the
time course of the analgesic response. The model need not look like a
pharmacokinetic model. Indeed, the model for both analgesics was a
simple decrement in visual analog scale score that persisted over several
days.
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The net result was that the data were allowed to
forcefully speak to the underlying hypothesis. In the
case of wound instillation of capsaicin, the result went
from not being statistically significant, to being a large
effect (about 50% reduction in visual analog scale
score) that was significant at P  0.0001! The “tradi-
tional” analysis was essentially blind to an effect that
was visually obvious and enormously statistically
significant once interindividual variability was prop-
erly factored into the model.
The lesson to be learned is that mixed effect models
should become the standard approach for analysis of
analgesic trials. Mixed effect models can be imple-
mented with many programs, including SAS, R, and S
plus. However, NONMEM is optimized for such
approaches, has been vetted by over two decades of
testing, and has thousands of active users able to help
investigators implement these approaches.
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